| 3Rs | Reduction, Replacement, Refinement |
| AChE | Acetylcholinesterase |
| AD | Alzheimer’s disease |
| AMPK | Adenosine 5‘-monophosphate (AMP)-activated protein kinase |
| APP/PS1 | (APPswe,PSEN1dE9); APP: Amyloid precursor protein |
| Aβ | Amyloid-β |
| BACE1 | Beta-site amyloid precursor protein cleaving enzyme 1 |
| BchE | Butyrylcholinesterase |
| CAT | Catalase from Micrococcus Lysodeikticus |
| CNS | Central nervous system |
| CON | Control group |
| DD H2O | Double distilled water |
| EX | Exercise |
| EX+GCA | Exercise+ Chlorogenic acid |
| FDA | U.S. Food and Drug Administration |
| GAPDH | Glyceraldehyde -3-phosphate dehydrogenase |
| GCA | Chlorogenic acid |
| GSH-PX | Glutathione peroxidase |
| H2O2 | Hydrogen peroxide |
| HE | Hematoxylin-eosin staining |
| IL-10 | Interleukin-10 |
| IL-1β | Interleukin-1β |
| IL-6 | Interleukin-6 |
| LC3 | MAP1LC3 |
| MAP2 | (Microtubule-associated protein) 2 |
| MDA | Malondialdehyde |
| NeuN | Neuronal nuclei antigen (NeuN /RBFOX3) |
| OD | Optical density |
| PBS | Phosphate buffered saline |
| PGC-1α | Peroxisome proliferators-activated receptor γ coactivator l alpha |
| PPARγ | Peroxisome proliferator activated receptor γ |
| ROS | Reactive oxygen species |
| SIRT1 | Silent Information Regulator 1 |
| SOD | Superoxide dismutase |
| TNF-α | Tumor necrosis factor-α |
| WB | Western blot |